Removal of contaminating polymorphonuclear leukocytes to prepare purified lymphocytes for cytotoxicity testing

Tissue Antigens
|August 1, 1980
PubMed

Insights

Human polymorphonuclear leukocytes (PMN) can interfere with histocompatibility testing. A new method effectively removes PMN, improving the accuracy of microcytotoxicity test results by reducing dead cell background.

Area of Science:

  • Immunology
  • Cell Biology
  • Histocompatibility Testing

Background:

  • Human polymorphonuclear leukocytes (PMN) exhibit non-specific cell death during standard tissue typing assays.
  • High concentrations of PMN (>20%) in cell preparations complicate the accurate evaluation of histocompatibility assays.
  • PMN aggregation observed with normal rabbit serum (complement source) provided a basis for developing a new technique.

Purpose of the Study:

  • To develop a simple and effective method for reducing polymorphonuclear leukocyte (PMN) contamination in lymphocyte preparations.
  • To improve the accuracy and reliability of histocompatibility testing by minimizing PMN-related interference.
  • To enhance the evaluation of microcytotoxicity test results.

Main Methods:

  • A novel technique was developed leveraging PMN aggregation in the presence of normal rabbit serum.
  • This method selectively removes PMN from lymphocyte suspensions.
  • The procedure aims to maintain high yields of viable lymphocytes.

Main Results:

  • The developed technique successfully reduces PMN contamination in cell suspensions.
  • The removal of PMN significantly lowers the background of dead cells in the assay.
  • This leads to a precise and reliable evaluation of microcytotoxicity test results.

Conclusions:

  • A simple method for PMN removal effectively enhances histocompatibility assay accuracy.
  • Reducing PMN contamination is crucial for precise microcytotoxicity testing.
  • This technique offers a valuable improvement for immunological and transplantation diagnostics.

Related Concept Videos